Hepatitis Monthly

Published by: Kowsar

Prevalence and Risk Factors for Obesity After Liver Transplantation: A Single-Center Experience

Mesut Akarsu 1 , * , Yasin Bakir 1 , Sedat Karademir 2 , Tarkan Unek 2 , Aylin Bacakoglu 2 and Ibrahim Astarcioglu 2
Authors Information
1 Division of Gastroenterology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey
2 Department of Hepatobiliary Surgery and Liver Transplantation, Dokuz Eylül University, Izmir, Turkey
Article information
  • Hepatitis Monthly: August 2013, 13 (8); e7569
  • Published Online: August 1, 2013
  • Article Type: Research Article
  • Received: August 2, 2012
  • Revised: February 15, 2013
  • Accepted: May 25, 2013
  • DOI: 10.5812/hepatmon.7569

To Cite: Akarsu M, Bakir Y, Karademir S, Unek T, Bacakoglu A, et al. Prevalence and Risk Factors for Obesity After Liver Transplantation: A Single-Center Experience, Hepat Mon. 2013 ;13(8):e7569. doi: 10.5812/hepatmon.7569.

Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol. 2006; 5(2): 77-85[PubMed]
  • 2. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl. 2004; 10(7): 886-97[DOI][PubMed]
  • 3. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol. 2001; 96(3): 842-5[DOI][PubMed]
  • 4. Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int. 2005; 18(4): 461-6[DOI][PubMed]
  • 5. Verdonk RC, van den Berg AP, Slooff MJ, Porte RJ, Haagsma EB. Liver transplantation: an update. Neth J Med. 2007; 65(10): 372-80[PubMed]
  • 6. Nair S, Vanatta JM, Arteh J, Eason JD. Effects of obesity, diabetes, and prior abdominal surgery on resource utilization in liver transplantation: a single-center study. Liver Transpl. 2009; 15(11): 1519-24[DOI][PubMed]
  • 7. T. D. Correia MI, Rego LO, Lima AS. Post-liver transplant obesity and diabetes. Curr Opin Clin Nutr Metab Care. 2003; 6(4): 457-60[DOI][PubMed]
  • 8. Wawrzynowicz-Syczewska M, Karpinska E, Jurczyk K, Laurans L, Boron-Kaczmarska A. Risk factors and dynamics of weight gain in patients after liver transplantation. Ann Transplant. 2009; 14(3): 45-50[PubMed]
  • 9. Gultekin T, Ozer BK, Akin G, Bektas Y, Sagir M, Gulec E. Prevalence of overweight and obesity in Turkish adults. Anthropol Anz. 2009; 67(2): 205-12[PubMed]
  • 10. Hatemi H, Yumuk VD, Turan N, Arik N. Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord. 2003; 1(4): 285-90[DOI][PubMed]
  • 11. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg. 1998; 4(4): 285-96[PubMed]
  • 12. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation. 2000; 69(5): 781-9[PubMed]
  • 13. Neal DA, Gimson AE, Gibbs P, Alexander GJ. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Liver Transpl. 2001; 7(6): 533-9[DOI][PubMed]
  • 14. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 2008; 14(11): 1648-54[DOI][PubMed]
  • 15. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg. 2002; 183(5): 595-9[PubMed]
  • 16. Richardson RA, Garden OJ, Davidson HI. Reduction in energy expenditure after liver transplantation. Nutrition. 2001; 17(7-8): 585-9[PubMed]
  • 17. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg. 1997; 3(1): 1-9[PubMed]
  • 18. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation. 1995; 60(9): 1057-60[PubMed]
  • 19. Palmer M, Schaffner F, Thung SN. Excessive weight gain after liver transplantation. Transplantation. 1991; 51(4): 797-800[PubMed]
  • 20. Krentz AJ, Dousset B, Mayer D, McMaster P, Buckels J, Cramb R, et al. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes. 1993; 42(12): 1753-9[PubMed]
  • 21. Becker T, Foltys D, Bilbao I, D'Amico D, Colledan M, Bernardos A, et al. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation. 2008; 86(12): 1689-94[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader